SmartTRAK Life Sciences News and Analysis Blog

Natasha Weeks

13 years' experience in marketing and product development, including 5+ years at DePuy Synthes Trauma - most recently as Product Director at DePuy Synthes Trauma.

Trends and Advancements in Foot & Ankle: AOFAS 2022

By Natasha Weeks on 11/17/22 9:38 AM

SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFAS 2022

SmartTRAK identified several key themes and takeaways from the American Orthopaedic Foot & Ankle Society (AOFAS) 2022 meeting held recently in Quebec City, Canada. Manufacturers showcased product introductions with a continued focus on hallux valgus solutions and are investing in solutions beyond implants to differentiate themselves and gain share in the US Foot & Ankle Market.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

Small, Niche Players Attempt to Gain Share
- Globus Fills Out Trauma and Extremities Product Portfolios
- Enovis Showcases New Products and Gains Traction in F&A Space
Direct-To-Consumer Marketing Drives Growth in Hallux Valgus Market
- Treace Medical Outpaces Others
- Medartis Showcases New Products
- JNJ/DePuy/Synthes' Acquisition
- Paragon28 Focuses on the MIS Segment

To download the complete "AOFAS 2022: Trends and Advancements in Foot & Ankle" article by SmartTRAK's Natasha Weeks, Sr. Analyst, Trauma & Extremities, just click the button below.

Topics: Orthopedics Trauma Extremities

2 min read

Trends and Advancements in Trauma: OTA 2022

By Natasha Weeks on 11/14/22 11:34 AM

SmartTRAK highlights the latest trends and innovations at OTA 2022, with a focus on deformity correction and limb lengthening.

Our expert analysts focus in on the latest advancements, key trends and takeaways from the Orthopedic Trauma Association (OTA) meeting in Tampa, Florida held October 12–15, 2022. Major trauma manufacturers showcased innovation through new product introductions.

Stepping Outside of Internal Fixation

In the market for ring fixation devices, companies have been innovating beyond static frames and are developing dynamic, computer-assisted hexapod frames to treat bone fractures and deformity corrections. One of the challenges with hexapod frames is that they require manual strut adjustments, a process that is prone to patient and clinician error and can require up to 20 manual adjustments per day—a definite burden on the patient and caregiver ...

Topics: Top Story Trauma Extremities

2 min read

New Products Will Drive Growth: Q222 Trauma Market Recap

By Natasha Weeks on 9/19/22 9:24 AM

Quarterly growth stalled due to weather, supply chain and staffing, but the promise of new product introductions in H2 will return healthy growth to the Trauma Market.

The Q222 Trauma Market was impacted by several conditions that contributed to decelerating growth, such as a reduced demand for trauma-related devices, supply chain challenges and facility staffing hurdles. The WW Trauma Market growth slowed sequentially in Q2, down compared to Q122’s growth. The US Trauma Market fared a bit better than WW results, but also experienced a sequential slump compared to Q122. For the first half of 2022, the US Trauma Market was up +3.5% YTD growth compared to H121.

Among the many topics covered in detail in our comprehensive Q222 Trauma Market Recap* are:

Complete Q222 Trauma Overview and Highlights
SmartTRAK's Expert Analysis and Insights
All Company News including Revenues, Data, Charts and Shares
Mergers & Acquisitions
Q222 Trauma Regulatory Highlights

Topics: Trauma

2 min read

Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap

By Natasha Weeks on 7/28/22 9:30 AM

Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisitions were plentiful and regulatory clearances show promise of future new product introductions.

Topics: Orthopedics Trauma

2 min read

New Products Offset COVID Headwinds: Q421/FY21 Trauma Market Recap

By Natasha Weeks on 3/31/22 9:30 AM

New product introductions offset slightly weaker Q4 results due to COVID-19 headwinds and international pressure.

While the Trauma segment was not impacted as heavily due to COVID-19 headwinds, companies that play within the space were impacted by deferrals of elective surgeries such as limb restoration. Long bone trauma volumes remained healthy as players cited new product introductions as growth drivers for the segment.

Among the many topics covered in detail in our comprehensive Q421/FY21 Trauma Market Recap* are:

Topics: Orthopedics Trauma

2 min read

Riding the Wave of Healthy Growth: Q321 Trauma Market Recap

By Natasha Weeks on 12/27/21 4:01 PM

Trauma market continues to ride the wave of healthy growth with positive returns for current players and new players start to stir the waters

Trauma players rode the wave of another quarter of healthy returns as trauma procedures were not as impacted by the rise in the Delta variant as its elective procedure counterparts. The Trauma Market closed Q3 up +4.5% YoY compared to Q320, with the US up +5.8% YoY.

Among the many topics covered in detail in our comprehensive Q321 Trauma Market Recap* are:

Topics: Trauma

6 min read

SmartTRAK's 2021 AOFAS Meeting Highlights

By Natasha Weeks on 10/21/21 9:30 AM

New product introductions and innovative technologies set the stage for AOFAS 2021.

At the American Orthopaedic Foot & Ankle Society (AOFAS) meeting in Charlotte, NC, SmartTRAK identified several key themes and takeaways from the meeting as manufacturers showcased innovation through new product introductions, continue to focus on hallux valgus corrections and the associated instrumentation allowing for reproducible outcomes and the advancements of 3D printed solutions.

The Luster of New Products Help Drive Healthy Foot & Ankle Competition

The foot & ankle space does not look like it is slowing down anytime soon based on the products highlighted at AOFAS. Innovation is helping to drive growth in the US market for Foot & Ankle Repair and Reconstruction, which is projected to reach a 5-year CAGR of +4.9% according to SmartTRAK’s Foot & Ankle Market Overview. Newsworthy highlights include:

Topics: Orthopedics

2 min read

Another Quarter of Healthy Growth: Q221 Trauma Market Recap

By Natasha Weeks on 9/22/21 4:00 PM

Trauma market rebounds as top segments drive growth amid easy YoY comps

The Trauma Market experienced another quarter of healthy growth as the WW and US Trauma Markets ended Q221 up YoY compared to Q220. Looking forward to Q321, SmartTRAK feels that trauma procedures will likely not be as heavily impacted by the rise in the Delta variant as its elective procedure counterparts. We will continue to monitor the situation as the variant impacts states, as recently observed in Texas.

Among the many topics covered in detail in our comprehensive Q221 Trauma Market Recap* are:

Topics: Orthopedics Trauma

2 min read

Another Quarter of Healthy Growth: Q121 Trauma Market Recap

By Natasha Weeks on 6/11/21 9:30 AM

Inclement weather, strong product performances and the impact of M&A all help to drive another quarter of healthy growth for the Trauma Market.

The Trauma Market experienced the third sequential quarter of increasingly healthy growth as both the WW and US Trauma Markets were up YoY. New product introductions, along with inclement weather in the US and EU drove trauma procedures during the first quarter of 2021.

During the Stryker Q121 earnings call, management noted that their trauma business, which is less elective in nature, benefited from inclement weather in the US and Europe in February.

Among the many topics covered in detail in our comprehensive Q121 Trauma Market Recap* are:

Topics: Orthopedics

2 min read

Healthy Growth in Q420: Q420/FY20 Trauma Market Recap

By Natasha Weeks on 3/22/21 12:16 PM

Healthy growth closes out Q420 as the trauma segment recovers in the second half of the year hitting pre-COVID levels.

Despite the rise in COVID cases during Q4, the Trauma Market fared well resulting in positive YoY revenue gains that represented healthy, pre-COVID level volumes. Trauma players cited another quarter of healthy trauma growth, as the second half of the year ended on an upswing (+5.6% vs. H219). Top US market leaders, DePuy Synthes (49.4% Q420 US share), Stryker (27.3%) and Smith & Nephew (9.8%) all reported improved sequential gains.

Among the many topics covered in the comprehensive Q420/FY20 Trauma Market Recap* are:

Topics: Orthopedics Trauma